Oxidase activity of ceruloplasmin and some acute phase reactant and trace element concentrations in serum of patients with chronic lymphocytic leukemia

被引:12
|
作者
Gundogdu, M. [1 ]
Kaya, H.
Gulcin, I.
Erdem, F.
Cayir, K.
Keles, M.
Yilmaz, A.
机构
[1] Ataturk Univ, Sch Med, Dept Internal Med, TR-25240 Erzurum, Turkey
[2] Mustafa Kemal Univ, Dept Internal Med, Sch Med, Antakya, Turkey
[3] Dept Chem Sci & Art Fac, Erzurum, Turkey
[4] Nenehatun Obstetr & Gynecol Hosp, Dept Biochem, Erzurum, Turkey
关键词
D O I
10.1258/rsmsmj.52.1.24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the present study, we aimed to investigate the parameters in serum of patients with chronic lymphocytic leukaemia (CLL) and correlate with the cancer stage. The serum concentrations of ceruloplasmin, a-1-acid glycoprotein, albuminumin, transferrin, copper, zinc, manganese, and ceruloplasmin oxidase activity were measured, and compared with those from a healthy control group. The serum from 34 patients with CLL were extracted before chemotherapy. Serum transferrin, allbuminumin and Zinc concentrations were lower in patients with CLL while serum a-1-acid glycoprotein, ceruloplasmin, copper concentrations, and ceruloplasmin oxidase activity were higher in CLL patients when compared with the control group. Although serum manganese concentration was lower in CLL groups than in the control group, the difference was not statistically significant. Serum transferrin concentration was lower in the early stage group compared with the advanced stage. Serum ceruloplasmin level positively correlated with serum ceruloplasmin oxidase activity in patients from the early stage group. Serum ceruloplasmin level positively correlated with serum ceruloplasmin oxidase activity in patients with advanced stage. In conclusion, increased serum ceruloplasmin oxidase activity, ceruloplasmin, a-1-acid glycoprotein, copper levels and decreased transferrin and albuminumin, unchanged manganese levels are associated with CLL and appear to be a consequence of the disease itself.
引用
收藏
页码:24 / 27
页数:4
相关论文
共 46 条
  • [41] Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naive, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study
    Davids, Matthew S.
    Chanan-Khan, Asher
    Mudenda, Boyd
    Nogaieva, Larysa
    Kriachok, Iryna
    Usenko, Hanna
    Ivanov, Vladimir
    Kyselova, Olena
    Perekhrestenko, Tetiana
    Muzhychuk, Ivan
    Myasnikov, Alexander
    Maslyak, Zvenyslava
    Proidakov, Andrew
    Uspenskaya, Olga
    Borisenkova, Elena
    Marlton, Paula
    Siddiqi, Tanya
    Winter, Allison
    Lysa, Tamila
    Bakirov, Bulat
    Fu, Lei
    Chen, Zi
    Yu, Min
    Li, Mingyu
    Glass, Laura
    Ahmad, Mohammad
    Karpenko, Olena
    Osipov, Iurii
    De, Asit
    Paudyal, Ben
    Wang, Hengbang
    Winkler, Robert
    Gabrail, Nashat
    Ganju, Vinod
    Konstantinova, Tatiana S.
    Samoylova, Olga S.
    Yang, Dajun
    Zhai, Yifan
    BLOOD, 2022, 140 : 2326 - 2328
  • [42] TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE ACTIVITIES IN HUMAN-BLOOD LEUKOCYTES AND LYMPHOBLAST CELL LINES - HIGH LEVELS IN LYMPHOBLAST CELL LINES AND IN BLAST CELLS OF SOME PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN ACUTE PHASE
    SARIN, PS
    ANDERSON, PN
    GALLO, RC
    BLOOD, 1976, 47 (01) : 11 - 20
  • [43] Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial
    Wierda, William G.
    Kipps, Thomas J.
    Duerig, Jan
    Griskevicius, Laimonas
    Stilgenbauer, Stephan
    Mayer, Jiri
    Smolej, Lukas
    Hess, Georg
    Griniute, Rasa
    Hernandez-Ilizaliturri, Francisco J.
    Padmanabhan, Swaminathan
    Gorczyca, Michele
    Gupta, Ira
    Nielsen, Tina G.
    Russell, Charlotte A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (03) : E33 - E34
  • [44] Ofatumumab Combined with Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results From a Randomized, Multicenter, International, Two-Dose, Parallel Group, Phase II Trial
    Wierda, William G.
    Kipps, Thomas J.
    Duerig, Jan
    Griskevicius, Laimonas
    Stilgenbauer, Stephan
    Mayer, Jiri
    Smolej, Lukas
    Hess, Georg
    Griniute, Rasa
    Hernandez-Ilizaliturri, Francisco J.
    Padmanabhan, Swaminathan
    Gorczyca, Michele
    Chan, Geoffrey
    Gupta, Ira
    Andersen, Marc
    Strange, Claus
    Nielsen, Tina G.
    Russell, Charlotte A.
    BLOOD, 2009, 114 (22) : 90 - 91
  • [45] A Multi-Center, Open-Label, Phase I Study of Single Agent RG7112, A First In Class p53-MDM2 Antagonist, In Patients with Relapsed/Refractory Acute Myeloid and Lymphoid Leukemias (AML/ALL) and Refractory Chronic Lymphocytic Leukemia/Small Cell Lymphocytic Lymphomas (CLL/SCLL)
    Andreeff, Michael
    Kojima, Kensuke
    Padmanabhan, Swaminathan
    Strair, Roger
    Kirschbaum, Mark
    Maslak, Peter
    Hillmen, Peter
    O'Brien, Susan
    Samaniego, Felipe
    Borthakur, Gautam
    Konopleva, Marina
    Vassilev, Lyubomir
    Nichols, Gwen
    BLOOD, 2010, 116 (21) : 287 - 288
  • [46] Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Of a First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin's Lyphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
    Kuruvilla, John
    Gutierrez, Martin
    Shah, Bijal D.
    Gabrail, Nashat Y.
    Brown, Peter de Nully
    Stone, Richard M.
    Garzon, Ramiro
    Savona, Michael
    Siegel, David S.
    Baz, Rachid
    Mau-Sorensen, Morten
    Davids, Matthew S.
    Byrd, John C.
    Shacham, Sharon
    Rashal, Tami
    Yau, Cindy Y. F.
    McCauley, Dilara
    Saint-Martin, Jean-Richard
    McCartney, John
    Landesman, Yosef
    Klebanov, Boris
    Pond, Greg
    Oza, Amit M.
    Kauffman, Michael
    Mirza, Mansoor R.
    BLOOD, 2013, 122 (21)